Used on More Than
3 Million Patients*

Utilized in 1000+ hospitals nationwide following radial and femoral catheterization.

SyvekNT Can Reduce Time
to Ambulation to 1 Hour

One hour bedrest protocol using SyvekNT proved safe and effective in diagnostic patients.4

MORE     

SyvekExcel is Effective for
Anticoagulated Patients

  • Heparin1
  • Angiomax®(bivalirudin)1,3
  • Plavix®(clopidogrel)1,3
  • GPIIbIIIa-receptor antagonists1,3
  • Aspirin1,3
MORE     

Indications for Use: SyvekNT is intended for the promotion of rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. SyvekNT is intended for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement.
SyvekExcel is intended for use following femoral vascular catheterization procedures to assist in obtaining and maintaining hemostasis.

Safety Information:
PRECAUTIONS: There are no known contraindications to the use of SyvekNT. Longer compression may be necessary for hypertensive or obese patients.
There are no known contraindications to the use of SyvekExcel. Longer compression may be necessary for hypertensive or obese patients.
LATEX FREE
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner

Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.

1. Ghitis A, Cusnir H, Salajka H, et al. Cardiovasc Revasc Med. 2008; 9(2):128.
2. Hirsch JA, Reddy SA, Capasso WE,et al. Tech Vasc Interv Radiol. 2003;6:92-95.
3. Mego D, Thomas M, Stewart J, et al. J Invas Cardiol. 2010; 22:35-39
4. Palmer B, Gantt D, Lawrence M, et al. Am J Cardiol. 2004; 93:96-97

Angiomax®(bivalirudin) is a registered trademark of The Medicines Company
Plavix®(clopidogrel) is a registered trademark of Sanofi-Aventis

* Data on file, based on total US sales